Back Stocks profile

Stock analysis tool for investors

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE:500124

₹5966.60 10.40 (0.17%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

5888.00

Today’s High

5996.00

52W low

4867.00

52W High

6505.90

Open Price

5925.00

Prev. Close

5890.9500

Volume

375923.00

Value

2242982171.80

Fundamentals

Market Cap Cr

99540.60

Price to Earnings

17.80

Price to Book Value

3.50

Dividend Yield

0.70

PE to Growth

0.80

Op Revenue TTM Cr

28011.10

Net Profit TTM Cr

5577.90

Cash From Operating Activity Cr

4543.30

Return on Equity %

19.74

EMA & SMA

Bullish Moving Averages

5

Bearish Moving Averages

11

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

19 Jun, 2024

68.6

Week

63.2

Month

59.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5958.62

PIVOT

First Resistance

5997.23

Second Resistance

6038.27

Third Resistance

6076.88

First Support

5917.58

Second Support

5878.97

Third Support

5837.93

Relative Strength Index

48.7

Money Flow Index

41.96

MACD

14

MACD Signal

-4.24

Average True Range

122.83

Average Directional Index

13.33

Rate of Change (21)

2.49

Rate of Change (125)

6.56

Commodity Channel Index

18.4

Williams %R

-36.1

BETA

1 Month

0.28

3 Month

0.47

1 Year

0.35

3 Year

0.03

PRICE CHANGE ANALYSIS

-1.54%

1 Week

Low

High

5888

6119.9

2.67%

1 Month

Low

High

5600

6157.65

-2.74%

3 Months

Low

High

5600

6419.9

5.84%

6 Months

Low

High

5471.2

6505.9

22.29%

1 Year

Low

High

4867.05

6505.9

Bigul
18 Jun 2024

Dr Reddy's Laboratories, Warburg Pincus, EQT front-runners for BSV

New Delhi based Mankind Pharma too is in the fray, but it is taking a more conservative approach towards valuation
18 Jun 2024

DrReddy's Draws Analysts' Caution As Weak Global Macros Dent Outlook

If the current trends, even gRevlimid may not be able to mask the impact of weakness in the erosion of baseline product prices for Dr. Reddy's, Citi said.
Bigul
14 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of equity shares on exercise of Employee stock options
Bigul
13 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Bigul
13 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Bigul
13 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Filing of Annual Report in Form 20F for the fiscal year ended 31 March, 2024 with United States Securities and Exchange Commission
Bigul
12 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
See all News

FAQs

The latest market price of Dr. Reddy's Laboratories Ltd. on NSE was Rs. 5966.60 as of today.

The opening share price of Dr. Reddy's Laboratories Ltd. was Rs. 5925.00 as of today.

The 52-week high share price of Dr. Reddy's Laboratories Ltd. was Rs. 6505.90.

The 52 week low share price of Dr. Reddy's Laboratories Ltd. was Rs. 4867.00.

Dr. Reddy's Laboratories Ltd. has a market cap of Rs. 99540.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Dr. Reddy's Laboratories Ltd. is 0.80. Please refer to the Fundamentals section for further details.

The operating revenue for Dr. Reddy's Laboratories Ltd. in the last FY was Rs.  28011.10 crore. Please refer to the Financials section for further details.

The Net Profit for Dr. Reddy's Laboratories Ltd. in the last FY was Rs. 5577.90 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Dr. Reddy's Laboratories Ltd. was on 2023-07-11 for Rs. 40 per share. According to today’s share price, the dividend yield of Dr. Reddy's Laboratories Ltd. stands at 0.70. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Dr. Reddy's Laboratories Ltd. was as of 2006-08-28. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Dr. Reddy's Laboratories Ltd. was as of 2001-10-10. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Dr. Reddy's Laboratories Ltd..

Close

Let's Open Free Demat Account